In the cell and animal PD models induced by arsenite, arsenic exposure remarkably increased the m6A modification levels, while FTO was found to alleviate deficits in dopaminergic neurotransmission caused by arsenite [63]. The gene discussed is FTO; the disease is Parkinson disease.